New Generation Q-Switched Nd:YAG Laser with ReGenesis Mode and MLA Handpiece
CuRAS is the newest and most advanced Q-Switched Laser that provides the optimal performance for the treatment of tattoos, melasma,
non-ablative resurfacing and pigmented lesions. The new ReGENESIS treatment combines different pulse modes allowing you to target a wide range
of different skin concerns in one single CuRAS treatment.
CuRAS exclusive ReGENESISTM treatment allows practitioners to target the seven layers of ageing with a synergistic approach for maximum results. With four monthly treatments, the ReGENESISTM treatment utilises unique pulse modes and the MLA handpiece to target a multitude of concerns in a single treatment.
Product Videos and features
CuRAS superior energy stability and perfect beam profile enables stable thermal energy delivery to the target area for long treatment time resulting in uniform clinical efficacy and minimising damage to surrounding tissue.
Fast and RELIABLE
PTP mode delivers the high peak energy into twin pulse and allows the use of higher energy for an efficient treatment even at large spot size comparing with single pulse of energy. It also gives fast treatment and increased
Top Hat Beam Profile
The uniform even hat shape of beam profile means that CuRAS can deliver uniform and accurate – high quality beam – on the target area for reliability under its compact dual chamber.
Easy to Use
The spot size of the zoom hand piece is adjustable from 2 to 10mm with 1 mm adjustments in order to enable you to easily select the appropriate spot size for efficient treatments.
Preset Protocol & Storage Mode
Most frequent protocol is set for beginner and expert can save over 100 protocol for quick treatment preparation.
This Q-switched Nd:YAG laser system provides an efficient treatment for age or solar related lentigines and pigmented lesions, as well as reduction of pores. While the 1064nm Nd:YAG laser can be used for pigmented dermal lesions, pore reduction and skin rejuvenation, the 1064 nm / 532 nm combination is an effective choice for solar lentigines.
Professor Cemal Tahsin Gokhur Senyuva, M.D.
Our initial trial on the difference of reaction from CuRAS expert mode M-1064 shows promising results in terms of safety and efficacy for melasma in Southeast Asian patients.
Abraham Arimuko M.D